Moberg Derma and Paladin Labs Inc. (CC:PLB) Extends Agreement for Kerasal™ Nail to Mexico
5/13/2013 9:36:33 AM
More...
|
Health Canada Approves Paladin Labs Inc. (CC:PLB) Silenor New Drug Submission
12/18/2012 7:30:09 AM
More...
|
Paladin Labs Inc. (CC:PLB) Announces Agreement With QRxPharma Pty Ltd. for Up to $25 Million
10/10/2012 7:14:34 AM
More...
|
Nuvo Research Inc. (NRI.TO) and Paladin Labs Inc. (CC:PLB) Sign Canadian License Agreement for Synera and a Loan Agreement
5/29/2012 10:52:08 AM
More...
|
Paladin Labs Inc. (CC:PLB) Announces Canadian Approval for Oralair(TM)
3/21/2012 7:24:07 AM
More...
|
Paladin Labs Inc. (CC:PLB) and Somaxon Pharmaceuticals, Inc. (SOMX) Announce Filing of New Drug Submission for Silenor®
2/23/2012 6:07:32 AM
More...
|
Immuron Signs Distribution Deal Worth Up to $113 Million
11/29/2011 8:32:45 AM
More...
|
Labopharm Inc. (DDS.TO) Shareholders Vote To Approve Acquisition By Paladin Labs Inc. (CC:PLB)
10/5/2011 2:05:02 PM
More...
|
Valeant Pharmaceuticals International (VRX) Trumps Paladin Labs Inc. (CC:PLB) for Afexa Life Sciences Inc. With $78 Million Bid
9/26/2011 8:04:39 AM
More...
|
Valeant Pharmaceuticals International (VRX) Nabs Afexa Life Sciences Inc. for $76 Million Cash; Beats Paladin Labs Inc. (CC:PLB) to the Punch
8/30/2011 7:15:00 AM
More...
|
|